docetaxel anhydrous has been researched along with 12-o-undecadienoylphorbol-13-acetate in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (12-o-undecadienoylphorbol-13-acetate) | Trials (12-o-undecadienoylphorbol-13-acetate) | Recent Studies (post-2010) (12-o-undecadienoylphorbol-13-acetate) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 12 | 0 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldassari, F; Bergamini, CM; Bianchi, N; Galasso, M; Minotti, L; Volinia, S | 1 |
1 other study(ies) available for docetaxel anhydrous and 12-o-undecadienoylphorbol-13-acetate
Article | Year |
---|---|
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.
Topics: Carcinogenesis; Docetaxel; Doxorubicin; Exons; Female; Gene Expression Regulation, Enzymologic; GTP-Binding Proteins; Humans; K562 Cells; Male; Neoplasms; Oligonucleotide Array Sequence Analysis; Phorbol Esters; Protein Glutamine gamma Glutamyltransferase 2; RNA, Long Noncoding; Transglutaminases; U937 Cells | 2018 |